ArticleInternational journal of surgery (London, England)2024
Considerations regarding an updated meta-analysis of the optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II-III colon cancer.
Huayang Pang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.